Welcome to the new Outpatient Surgery website! Check out our login FAQs.
Product News
Great ideas for your OR
Publish Date: May 19, 2021   |  Tags:   Product News
Stimulating Relief for Chronic Back Pain
The FDA approved new labeling for Medtronic’s Intellis neurostimulator with Differential Target Multiplexed (DTM) programming based on a study that shows the technology is more effective than standard spinal cord stimulation in providing relief from chronic back pain. DTM is a proprietary waveform available on the Intellis platform, an implantable neurostimulator powered by battery technology that allows for faster recharge and a longer lifetime. The neurostimulator automatically adjusts stimulation administration based on the patient’s needs and preferences to ensure the correct pain-relieving therapy is delivered to the right location.
New to Outpatient Surgery Magazine?
Login or subscribe to continue reading this article